Literature DB >> 10985257

Macrophage-derived chemokine (MDC).

A Mantovani1, P A Gray, J Van Damme, S Sozzani.   

Abstract

Macrophage-derived chemokine (MDC) is a CC chemokine paradigmatic of emerging aspects of chemokine immunobiology. It is constitutively expressed, yet microbial products and cytokines regulate its expression with divergent effects of type II (IL-4 and IL-13) and type I (interferon) cytokines. Processing of the mature protein by dipeptidyl peptidase IV/CD26 provides a further level of regulation. It acts on diverse cellular targets including dendritic cells (DC), NK cells, and T cell subsets. Among these, MDC is a potent attractant for CCR4 expressing polarized Th2 and Tc2 cells, and evidence is consistent with a role of this chemokine as an amplification loop of polarized type II responses. Emerging indications on the involvement of MDC in diverse pathologies, ranging from allergic reactions to HIV infection and neoplasia, are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985257

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  63 in total

1.  Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

Authors:  P Fraticelli; M Sironi; G Bianchi; D D'Ambrosio; C Albanesi; A Stoppacciaro; M Chieppa; P Allavena; L Ruco; G Girolomoni; F Sinigaglia; A Vecchi; A Mantovani
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 2.  Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies.

Authors:  Manuel A R Ferreira
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

3.  Iloprost for asthma.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2011-01       Impact factor: 4.599

4.  Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma.

Authors:  Jared Klarquist; Kristen Tobin; Peyman Farhangi Oskuei; Steven W Henning; Manuel F Fernandez; Emilia R Dellacecca; Flor C Navarro; Jonathan M Eby; Shilpak Chatterjee; Shikhar Mehrotra; Joseph I Clark; I Caroline Le Poole
Journal:  Cancer Res       Date:  2016-09-12       Impact factor: 12.701

5.  A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.

Authors:  Alba A Brandes; Antoine F Carpentier; Santosh Kesari; Juan M Sepulveda-Sanchez; Helen R Wheeler; Olivier Chinot; Lawrence Cher; Joachim P Steinbach; David Capper; Pol Specenier; Jordi Rodon; Ann Cleverly; Claire Smith; Ivelina Gueorguieva; Colin Miles; Susan C Guba; Durisala Desaiah; Michael M Lahn; Wolfgang Wick
Journal:  Neuro Oncol       Date:  2016-02-21       Impact factor: 12.300

6.  The novel association of the chemokine CCL22 with abdominal aortic aneurysm.

Authors:  Jonathan Golledge; Paula Clancy; Corey Moran; Erik Biros; Catherine Rush; Philip Walker; Paul Norman
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

7.  Changes in immune cell distribution and their cytokine/chemokine production during regression of the rhesus macaque corpus luteum.

Authors:  Cecily V Bishop; Fuhua Xu; Rosemary Steinbach; Ellie Ficco; Jeffrey Hyzer; Steven Blue; Richard L Stouffer; Jon D Hennebold
Journal:  Biol Reprod       Date:  2017-06-01       Impact factor: 4.285

8.  Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis.

Authors:  A M Abu El-Asrar; S Struyf; S A Al-Kharashi; L Missotten; J Van Damme; K Geboes
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

9.  Abnormalities in chemokine levels in schizophrenia and their clinical correlates.

Authors:  Suzi Hong; Ellen E Lee; Averria Sirkin Martin; Benchawanna Soontornniyomkij; Virawudh Soontornniyomkij; Cristian L Achim; Chase Reuter; Michael R Irwin; Lisa T Eyler; Dilip V Jeste
Journal:  Schizophr Res       Date:  2016-09-17       Impact factor: 4.939

10.  Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.

Authors:  Seema Rawal; Fuliang Chu; Min Zhang; Hyun Jun Park; Durga Nattamai; Shibichakravarthy Kannan; Rakesh Sharma; David Delgado; Tina Chou; Heather Y Lin; Veerabhadran Baladandayuthapani; Amber Luong; Francisco Vega; Nathan Fowler; Chen Dong; R Eric Davis; Sattva S Neelapu
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.